Innovation and Information Center

Pearl Cohen Represents Opko Health Inc. In Its Newest Acquisition

Pearl Cohen Hosts Israel- Brazil Life Science Business Forum

Technion and GSK Sign Drug Development Deal

Neuronix Ltd. Closes a $5.5M Private Offering

Celsus Therapeutics PLC closes $9.2 Million Public Offering and Lists on NASDAQ

Pearl Cohen partners to lead “Business in Russia” conference

Pearl Cohen Names Five New Partners

EPO Abolishes Two-Year Time Limit for Divisional Applications

Proxy-advisors now dictate corporate processes

Patent Infringement Lawsuits Filed by Patent Trolls have a Tremendous Impact on Economies

Pearl Cohen Partners Named By Super Lawyers® New York Metro 2013 Edition

Pearl Cohen Represents $2.7 Billion OPKO Health, Inc. in Securing a Dual Listing for its Shares on the TASE